Fortress Biotech, Inc. (FBIO)
2.93
+0.06
(+2.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.93
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Debt to Equity Ratio : 0.3248 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3248 |
| March 31, 2026 | 0.3306 |
| December 31, 2025 | 1.348 |
| September 30, 2025 | 1.222 |
| June 30, 2025 | 1.576 |
| March 31, 2025 | 3.336 |
| December 31, 2024 | 3.341 |
| September 30, 2024 | 3.381 |
| June 30, 2024 | 4.946 |
| March 31, 2024 | 3.851 |
| December 31, 2023 | 3.930 |
| September 30, 2023 | 4.435 |
| June 30, 2023 | 4.561 |
| March 31, 2023 | 3.321 |
| December 31, 2022 | 3.102 |
| September 30, 2022 | 2.034 |
| June 30, 2022 | 1.541 |
| March 31, 2022 | 1.213 |
| December 31, 2021 | 0.6899 |
| September 30, 2021 | 0.9949 |
| June 30, 2021 | 0.9144 |
| March 31, 2021 | 0.9257 |
| December 31, 2020 | 0.8878 |
| September 30, 2020 | 0.782 |
| June 30, 2020 | 1.835 |
| Date | Value |
|---|---|
| March 31, 2020 | 2.977 |
| December 31, 2019 | 4.202 |
| September 30, 2019 | 4.261 |
| June 30, 2019 | 3.446 |
| March 31, 2019 | 5.253 |
| September 30, 2018 | 2.231 |
| June 30, 2018 | 1.913 |
| March 31, 2018 | 2.067 |
| December 31, 2017 | 1.265 |
| September 30, 2017 | 1.722 |
| June 30, 2017 | 0.6497 |
| March 31, 2017 | 0.6917 |
| December 31, 2016 | 0.733 |
| September 30, 2016 | 0.7482 |
| June 30, 2016 | 0.6171 |
| March 31, 2016 | 0.4656 |
| December 31, 2015 | 0.4077 |
| September 30, 2015 | 0.4344 |
| June 30, 2015 | 0.4157 |
| March 31, 2015 | 0.3991 |
| December 31, 2014 | 0.1986 |
| September 30, 2014 | 0.2023 |
| June 30, 2014 | 0.1936 |
| March 31, 2014 | 0.1856 |
| December 31, 2013 | 0.1675 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.831 |
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Kura Oncology, Inc. | 0.5049 |
| Spero Therapeutics, Inc. | 0.0462 |
| Cue Biopharma, Inc. | 3.813 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 316.72M |
| Total Liabilities (Quarterly) | 110.63M |
| Shareholders Equity (Quarterly) | 164.14M |
| Current Ratio | 3.959 |
| Net Debt Paydown Yield | 4.10% |